MENU

Herpes Serology: HSV-1 and HSV-2 Type-Specific Diagnosis from the Public Health Perspective

Sponsored by: DiaSorin
Speaker
  • Director, Public Health Laboratory, State of Tennessee Department of Health
    Biography
      Dr. Richard Steece is certified as the Public Health Laboratory Director at the State of Tennessee Department of Health. He came into this role with over 30 years of experience and is one of the nation's leading public health laboratory experts. Among his multiple admirable roles driving public health initiatives, Dr. Steece has recently served as the National Chlamydia Laboratory Coordinator for the Centers for Disease Control and Prevention (CDC) and as Science Advisor to the Association of Public Health Laboratories (APHL). Most recently, Dr. Steece is the incoming chair of the 2015 STD subcommittee for APHL, and he is continuing this appointment into 2016. Prior to his public health career working with every city, county and state public health laboratory in the US, Dr. Steece earned his PhD in Biology/Microbiology.

    Abstract

    Serology testing continues to be an indispensable tool for the management of several disease states, especially for the qualitative determination IgG antibodies to Herpes simplex virus Type 1 (HSV-1) or Herpes simplex virus Type 2 (HSV-2) in human serum.
     
    Come to this educational seminar to learn about key objectives in HSV-1 or HSV-2 type-specific diagnosis:

    • Examine how serology assays may be indicated in certain clinical scenarios: in sexually active adults or expectant mothers to aid in the presumptive diagnosis of HSV-1 or HSV-2 type-specific infection.
    • Discuss the US clinical guidelines regarding why HSV-1 and HSV-2 type-specific screening is not indicated in the general US population as it is for other STDs.
    • Describe diagnostic methods for diagnosing HSV-1 or HSV-2 type-specific infection: the differences between virologic and serologic assays and their usefulness in herpes diagnosis.

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    MAR 16, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources
    Attendees
    • See more